Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...

Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...

DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...

BofA keeps a Buy rating on DexCom (DXCM) with a $105 price target after Dexcom announced it received a warning letter from the FDA.

The investor has been working behind the scenes at the tech-services firm and isn't currently planning to nominate directors. The regulator said Robinhood had violated "numerous" rules, including ...

Brazil's Sao Paulo state confirmed on Friday a case of the new mpox strain, the first case of clade Ib mpox in the region, it said in a statement.

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...